Literature DB >> 19078986

Animal models of atopic dermatitis.

Haoli Jin1, Rui He, Michiko Oyoshi, Raif S Geha.   

Abstract

Atopic dermatitis (AD) is characterized by allergic skin inflammation. A hallmark of AD is dry itchy skin due, at least in part, to defects in skin genes that are important for maintaining barrier function. The pathogenesis of AD remains incompletely understood. Since the description of the Nc/Nga mouse as a spontaneously occurring model of AD, a number of other mouse models of AD have been developed. They can be categorized into three groups: (1) models induced by epicutaneous application of sensitizers; (2) transgenic mice that either overexpress or lack selective molecules; (3) mice that spontaneously develop AD-like skin lesions. These models have resulted in a better understanding of the pathogenesis of AD. This review discusses these models and emphasizes the role of mechanical skin injury and skin barrier dysfunction in eliciting allergic skin inflammation.

Entities:  

Mesh:

Year:  2009        PMID: 19078986      PMCID: PMC2886143          DOI: 10.1038/jid.2008.106

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  65 in total

1.  COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization.

Authors:  Dhafer Laouini; Abdala Elkhal; Ali Yalcindag; Seiji Kawamoto; Hans Oettgen; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2005-08       Impact factor: 10.793

2.  Stratum corneum chymotryptic enzyme in psoriasis.

Authors:  E Ekholm; T Egelrud
Journal:  Arch Dermatol Res       Date:  1999-04       Impact factor: 3.017

3.  Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions.

Authors:  C Vestergaard; H Yoneyama; M Murai; K Nakamura; K Tamaki; Y Terashima; T Imai; O Yoshie; T Irimura; H Mizutani; K Matsushima
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

4.  Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.

Authors:  Yi Chen; Claire L Langrish; Brent McKenzie; Barbara Joyce-Shaikh; Jason S Stumhofer; Terrill McClanahan; Wendy Blumenschein; Tatyana Churakovsa; Justin Low; Leonard Presta; Christopher A Hunter; Robert A Kastelein; Daniel J Cua
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 5.  The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis.

Authors:  Natalija Novak; Thomas Bieber
Journal:  J Am Acad Dermatol       Date:  2005-08       Impact factor: 11.527

6.  Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis.

Authors:  O Watanabe; K Natori; M Tamari; Y Shiomoto; S Kubo; Y Nakamura
Journal:  J Hum Genet       Date:  1999       Impact factor: 3.172

7.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

8.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.

Authors:  Claire L Langrish; Yi Chen; Wendy M Blumenschein; Jeanine Mattson; Beth Basham; Jonathan D Sedgwick; Terrill McClanahan; Robert A Kastelein; Daniel J Cua
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

9.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.

Authors:  Colin N A Palmer; Alan D Irvine; Ana Terron-Kwiatkowski; Yiwei Zhao; Haihui Liao; Simon P Lee; David R Goudie; Aileen Sandilands; Linda E Campbell; Frances J D Smith; Gráinne M O'Regan; Rosemarie M Watson; Jo E Cecil; Sherri J Bale; John G Compton; John J DiGiovanna; Philip Fleckman; Sue Lewis-Jones; Gehan Arseculeratne; Ann Sergeant; Colin S Munro; Brahim El Houate; Ken McElreavey; Liselotte B Halkjaer; Hans Bisgaard; Somnath Mukhopadhyay; W H Irwin McLean
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330

10.  Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin.

Authors:  Jane Yoo; Miyuki Omori; Dora Gyarmati; Baohua Zhou; Theingi Aye; Avery Brewer; Michael R Comeau; Daniel J Campbell; Steven F Ziegler
Journal:  J Exp Med       Date:  2005-08-15       Impact factor: 14.307

View more
  133 in total

1.  Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.

Authors:  Marijke Kamsteeg; Mieke Bergers; Roelie de Boer; Patrick L J M Zeeuwen; Stanleyson V Hato; Joost Schalkwijk; Geuranne S Tjabringa
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Curcumin inhibits epigen and amphiregulin upregulated by 2,4,6-trinitrochlorobenzene associated with attenuation of skin swelling.

Authors:  Hiroyasu Sakai; Ken Sato; Fumiaki Sato; Yuki Kai; Kazutaka Mandokoro; Kenjiro Matsumoto; Shinichi Kato; Tetsuro Yumoto; Minoru Narita; Yoshihiko Chiba
Journal:  Inflamm Res       Date:  2017-04-12       Impact factor: 4.575

3.  Whole-mount Confocal Microscopy for Adult Ear Skin: A Model System to Study Neuro-vascular Branching Morphogenesis and Immune Cell Distribution.

Authors:  Tomoko Yamazaki; Wenling Li; Yoh-Suke Mukouyama
Journal:  J Vis Exp       Date:  2018-03-29       Impact factor: 1.355

4.  Characterization of canine dendritic cells in healthy, atopic, and non-allergic inflamed skin.

Authors:  Meret Elisabeth Ricklin; Petra Roosje; Artur Summerfield
Journal:  J Clin Immunol       Date:  2010-07-31       Impact factor: 8.317

Review 5.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

6.  Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis.

Authors:  Alon Y Hershko; Ryo Suzuki; Nicolas Charles; Damiana Alvarez-Errico; Jennifer L Sargent; Arian Laurence; Juan Rivera
Journal:  Immunity       Date:  2011-10-06       Impact factor: 31.745

Review 7.  Itch mechanisms and circuits.

Authors:  Liang Han; Xinzhong Dong
Journal:  Annu Rev Biophys       Date:  2014       Impact factor: 12.981

8.  Therapeutic Effects of Tonsil-derived Mesenchymal Stem Cells in an Atopic Dermatitis Mouse Model.

Authors:  Harry Jung; Gil Myeong Son; Jae Jun Lee; Hae Sang Park
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 9.  Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases.

Authors:  Hariharan Subramanian; Kshitij Gupta; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2016-07-20       Impact factor: 10.793

10.  Complex 2B4 regulation of mast cells and eosinophils in murine allergic inflammation.

Authors:  Moran Elishmereni; Nanna Fyhrquist; Roopesh Singh Gangwar; Sari Lehtimäki; Harri Alenius; Francesca Levi-Schaffer
Journal:  J Invest Dermatol       Date:  2014-07-07       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.